Table 2. p63 is an independent predictor of MCC-specific survival.
Univariate and multivariate Cox regression analyses of MCC-specific mortality. HR: hazard ratio. 95% CI: 95% confidence interval.
Univariate | Multivariate | |||
---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | |
Stage II (vs. I) | 1.91 (0.6-5.9) | 0.27 | 2.33 (0.7-7.4) | 0.16 |
Stage III (vs. I) | 4.94 (2.0-12) | <0.001 | 4.92 (2.0-12) | <0.001 |
Stage IV (vs. I) | 15.8 (5.2-48) | <0.001 | 13.7 (4.3-44) | <0.001 |
Female (vs. male) | 0.53 (0.3-1.1) | 0.07 | 0.67 (0.3-1.4) | 0.27 |
Age at diagnosis (per 5 years older) |
1.11 (1.0-1.3) | 0.10 | 1.04 (0.9-1.2) | 0.61 |
p63 expressed in
tumor |
2.05 (1.1-3.6) | 0.02 | 2.05 (1.1-3.8) | 0.02 |